Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis

BACKGROUND: Intracoronary (IC) administration of glycoprotein IIb/IIIa inhibitors (GPIs) has been studied as an adjunctive therapy to improve outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention. In this systematic review and meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, JongSung, Jeon, Jinyoung, Geum, Min Jung, Lee, Hyun Woo, Shin, Jaekyu, Chung, Woo-Young, Yu, Yun Mi, Ah, Young-Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347711/
https://www.ncbi.nlm.nih.gov/pubmed/37452333
http://dx.doi.org/10.1186/s12959-023-00519-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347711/
https://www.ncbi.nlm.nih.gov/pubmed/37452333
http://dx.doi.org/10.1186/s12959-023-00519-x

Ejemplares similares